Taiwantrade to Showcase Award-Winning Food Innovations at Food Taipei 2025
TAIPEI, June 17, 2025 /PRNewswire/ -- Taiwantrade.com – the go-to B2B sourcing platform for premium Taiwanese products, is thrilled to announce its participation in Food Taipei 2025. The event will take place from June 25 to June 28 at booth Q1230, Hall 2, Taipei Nangang Exhibition Center.
At the Taiwantrade booth, visitors will experience a curated selection of Taiwan's finest food and beverage innovations. Highlights include live demonstrations of KLUB's Teapresso machine, offering freshly brewed tea on-site for guests to enjoy. Visitors will also get the opportunity to taste award-winning food products, including:
Taro balls by Taro Yuan (iTQi 1 star 2023)
The Caramel Almond Boat by ISABELLE (TAIWAN) CO., LTD. (iTQi 1 star 2022)
Instant Popping Boba Drink by puly (Gold award by Monde Selection 2025 and iTQi 2 stars 2022)
Taiwantrade.com is also extending the exhibition experience online through its dedicated Food Industry Pavilion — now live at: https://foodpavilion.taiwantrade.com/home.html The online pavilion features over 30,000 high-quality food-related products from over 4,000 Taiwanese suppliers, including snacks, beverages, frozen foods, Halal-certified items, vegetarian products, and food machinery. Global buyers can easily browse and source from Taiwan's top exporters — all in one place.
About TaiwantradeTaiwantrade.com is Taiwan's largest B2B sourcing platform, offering free access to over 660,000 products from more than 72,000 verified Taiwanese suppliers. The platform connects global buyers with reliable manufacturers. To help buyers connect with suppliers, Taiwantrade.com offers a range of customized sourcing services, including the "Meet Supplier Online" program. For more details, visit www.taiwantrade.com.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/taiwantrade-to-showcase-award-winning-food-innovations-at-food-taipei-2025-302482653.html
SOURCE Taiwantrade.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
19 minutes ago
- Business Wire
STARLUX Airlines Named SKYTRAX 5-Star Airline for 2025
TAIPEI, Taiwan & PARIS--(BUSINESS WIRE)--Taiwan-based luxury carrier STARLUX Airlines has been awarded the highest rating of 5-Star Airline for 2025 by SKYTRAX, the world's leading airline rating organization. STARLUX officially joins the ranks of the world's top carriers recognized for exceptional quality across all aspects of the passenger journey. The announcement was made at the 2025 World Airline Awards in Paris, where STARLUX was also honored with the World's Most Improved Airline award. SKYTRAX is globally regarded as the benchmark for excellence in the aviation industry. This recognition marks a significant milestone for STARLUX airlines, which launched operations in 2020. In just five years, STARLUX has achieved global prominence with rapid growth, a strong commitment to service excellence, and a clear vision to redefine premium travel from Asia. Commenting on this achievement, STARLUX Airlines CEO, Glenn Chai, who accepted the awards in Paris, said: 'Receiving the 5-Star Airline award is an honor and a tremendous encouragement for everyone at STARLUX. We launched operations in 2020, so reaching this milestone highlights our team's resilience and passion. We are thrilled and deeply grateful for our passengers' trust and the dedication of our team. STARLUX will continue expanding our network and raise the bar on safety and service, offering travelers around the world a warm and refined service in the sky.' Edward Plaisted, CEO of Skytrax said: 'Certifying STARLUX Airlines with the highest 5-Star Airline Rating is a testament to their focus on delivering a high-quality passenger experience, and this top accolade demonstrates how STARLUX Airlines excel in key areas such as cabin comfort, catering, with a very accomplished service delivery onboard each flight.' With an expanding long-haul network, STARLUX currently operates routes in the United States to Los Angeles, San Francisco, Seattle, and Ontario, CA. In February 2026, the airline will launch a new nonstop service to Phoenix, becoming the first carrier to offer direct flights between Arizona and Asia. As STARLUX prepares to introduce more new aircraft in 2025 and 2026, it is accelerating its growth in both medium- and long-haul operations. STARLUX remains dedicated to offering seamless, premium service across every detail of the journey, while further establishing its presence in North America and beyond. About STARLUX Airlines Founded on the philosophy that luxury should be available to everyone, not just the elite, Taiwan-based STARLUX is a boutique international airline serving a total of 29 destinations from Taiwan to the US, Japan, Macau, Vietnam, Thailand, Philippines, Malaysia, and Singapore. STARLUX passengers traveling between Asia and North America are able to enjoy an easy transfer in Taipei with its four US routes: Taipei-Los Angeles, Taipei-San Francisco, Taipei-Seattle and Taipei-Ontario. In Q1 2026, STARLUX will launch its fifth U.S. destination—Phoenix, further strengthening its transpacific network. STARLUX prioritizes safety and offers unparalleled service with the goal of making flying a truly luxurious and unforgettable experience. For more information, visit or on our social channels Facebook and Instagram. About SKYTRAX SKYTRAX is a UK-based international air transport rating organization that was established in 1989. It is best known for its annual World Airline Awards, which are considered among the most prestigious accolades in the aviation industry. Through comprehensive passenger surveys and professional audits, SKYTRAX evaluates airlines and airports across the globe based on quality standards and customer satisfaction. Their trusted ratings and rankings help travelers make informed decisions and encourage continuous improvement across the air travel sector.
The Verge
24 minutes ago
- The Verge
DJI is now six months away from a US ban — it wants you to ‘make your voice heard now.'
Sean Hollister It sounds ridiculous when I say it out loud: A Chinese company wants to be audited by the US government, and it's asking you for help! But it's true: Every new DJI product will be banned from import as soon as December, unless a gov agency positively confirms the dronemaker doesn't pose a national security threat. 'More than six months have passed, and that process still hasn't begun as far as we can tell,' writes DJI.
Yahoo
29 minutes ago
- Yahoo
The 46,000% Biotech Rocket: How a No-Revenue Stock Hit $30 Billion
Regencell (NASDAQ:RGC) has pulled off one of the most surreal runs in market memory soaring over 46,000% year-to-date, catapulting from a $53 million microcap to a nearly $30 billion juggernaut. The Hong Kong-based biotech, which listed on Nasdaq in 2021, specializes in traditional Chinese medicine aimed at treating neurological disorders and COVID-19. And yet, it hasn't generated a single dollar in revenue since inception. Earlier this month, the company executed a 38-for-1 stock split a move that sent shares up 283% in one day and triggered more than 10 trading halts. The stock's tiny float and frenzied momentum may be doing more heavy lifting than anything on the balance sheet. Warning! GuruFocus has detected 2 Warning Signs with RGC. Regencell's formula is rooted in herbal compounds "no synthetic ingredients," the company says targeting conditions like ADHD and autism. It also claimed its therapy reduced COVID symptoms in six days during a 2022 trial, though the results haven't been peer-reviewed. The firm itself has acknowledged it hasn't filed for regulatory approval, holds no patents, and has no distribution channels. It ended its last fiscal year with a $4.4 million net loss and continues to fund operations largely through shareholder loans and IPO proceeds. Still, the company's narrative natural medicine meets neurological care has attracted a wave of speculative attention. Like many early-stage biotech firms, Regencell is bleeding cash but it's doing so with a surprisingly thick cushion. As shown in the chart below, the company raised a sizable cash pile from 2022 through 2024, even as its debt levels remained relatively modest. This financial buffer may be buying Regencell time to run trials and fund operations while retail traders do the rest. What's possibly fueling this rocket? Just 6% of Regencell's 500 million shares are available for trading. The rest 86% is held by insiders, mostly CEO Yat-Gai Au. That ultra-low float dynamic can turbocharge even modest demand into massive price moves. For investors, this is either a once-in-a-decade asymmetrical upside or a gravity-defying bubble waiting to reset. With no news, no revenue, and no roadmap from management, the Regencell frenzy raises more questions than answers but for now, the market can't seem to look away. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
